PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ANAMORELIN HCL
Clinical Trial Grant
Awarded By
Helsinn Healthcare S.A.
Start Date
May 9, 2019
End Date
February 13, 2024
Awarded By
Helsinn Healthcare S.A.
Start Date
May 9, 2019
End Date
February 13, 2024